Global Edoxaban Tosilate Orally Disintegrating Tablets Market Growth 2026-2032
The global Edoxaban Tosilate Orally Disintegrating Tablets market size is predicted to grow from US$ 1982 million in 2025 to US$ 4439 million in 2032; it is expected to grow at a CAGR of 12.4% from 2026 to 2032.
Edoxaban Tosilate Orally Disintegrating Tablets are a type of anticoagulant medication designed to prevent and treat conditions related to blood clots, such as deep vein thrombosis, pulmonary embolism, and stroke prevention in patients with non-valvular atrial fibrillation. The active ingredient, edoxaban, is a direct Factor Xa inhibitor, which works by interrupting the blood clotting cascade and reducing the risk of clot formation. These tablets are formulated to disintegrate quickly in the mouth without the need for water, making them particularly convenient for patients who have difficulty swallowing traditional tablets. This delivery method ensures ease of administration while maintaining therapeutic efficacy.
The market for Edoxaban Tosilate Orally Disintegrating Tablets is driven by the rising prevalence of thromboembolic disorders, such as deep vein thrombosis, pulmonary embolism, and stroke associated with atrial fibrillation. With increasing awareness of the importance of anticoagulation therapy and the growing geriatric population at higher risk of clotting disorders, demand for user-friendly and effective anticoagulant formulations has surged. Orally disintegrating tablets, offering enhanced patient compliance due to their convenience and ease of administration, particularly benefit individuals with swallowing difficulties. Market growth is further supported by advancements in drug delivery technologies and the expansion of healthcare access in emerging economies. However, challenges such as high treatment costs, potential bleeding risks, and competition from alternative anticoagulants may restrain growth. Regulatory approvals and strategic collaborations among pharmaceutical companies are expected to play a key role in shaping the market's trajectory.
LP Information, Inc. (LPI) ' newest research report, the “Edoxaban Tosilate Orally Disintegrating Tablets Industry Forecast” looks at past sales and reviews total world Edoxaban Tosilate Orally Disintegrating Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Edoxaban Tosilate Orally Disintegrating Tablets sales for 2026 through 2032. With Edoxaban Tosilate Orally Disintegrating Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Edoxaban Tosilate Orally Disintegrating Tablets industry.
This Insight Report provides a comprehensive analysis of the global Edoxaban Tosilate Orally Disintegrating Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Edoxaban Tosilate Orally Disintegrating Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Edoxaban Tosilate Orally Disintegrating Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Edoxaban Tosilate Orally Disintegrating Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Edoxaban Tosilate Orally Disintegrating Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Edoxaban Tosilate Orally Disintegrating Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Edoxaban Tosilate Orally Disintegrating Tablets are a type of anticoagulant medication designed to prevent and treat conditions related to blood clots, such as deep vein thrombosis, pulmonary embolism, and stroke prevention in patients with non-valvular atrial fibrillation. The active ingredient, edoxaban, is a direct Factor Xa inhibitor, which works by interrupting the blood clotting cascade and reducing the risk of clot formation. These tablets are formulated to disintegrate quickly in the mouth without the need for water, making them particularly convenient for patients who have difficulty swallowing traditional tablets. This delivery method ensures ease of administration while maintaining therapeutic efficacy.
The market for Edoxaban Tosilate Orally Disintegrating Tablets is driven by the rising prevalence of thromboembolic disorders, such as deep vein thrombosis, pulmonary embolism, and stroke associated with atrial fibrillation. With increasing awareness of the importance of anticoagulation therapy and the growing geriatric population at higher risk of clotting disorders, demand for user-friendly and effective anticoagulant formulations has surged. Orally disintegrating tablets, offering enhanced patient compliance due to their convenience and ease of administration, particularly benefit individuals with swallowing difficulties. Market growth is further supported by advancements in drug delivery technologies and the expansion of healthcare access in emerging economies. However, challenges such as high treatment costs, potential bleeding risks, and competition from alternative anticoagulants may restrain growth. Regulatory approvals and strategic collaborations among pharmaceutical companies are expected to play a key role in shaping the market's trajectory.
LP Information, Inc. (LPI) ' newest research report, the “Edoxaban Tosilate Orally Disintegrating Tablets Industry Forecast” looks at past sales and reviews total world Edoxaban Tosilate Orally Disintegrating Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Edoxaban Tosilate Orally Disintegrating Tablets sales for 2026 through 2032. With Edoxaban Tosilate Orally Disintegrating Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Edoxaban Tosilate Orally Disintegrating Tablets industry.
This Insight Report provides a comprehensive analysis of the global Edoxaban Tosilate Orally Disintegrating Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Edoxaban Tosilate Orally Disintegrating Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Edoxaban Tosilate Orally Disintegrating Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Edoxaban Tosilate Orally Disintegrating Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Edoxaban Tosilate Orally Disintegrating Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Edoxaban Tosilate Orally Disintegrating Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 30 mg
- 60 mg
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Daiichi Sankyo
- Menarini Group
- Simcere Pharmaceutical
- Lunan Pharmaceutical Group
- What is the 10-year outlook for the global Edoxaban Tosilate Orally Disintegrating Tablets market?
- What factors are driving Edoxaban Tosilate Orally Disintegrating Tablets market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Edoxaban Tosilate Orally Disintegrating Tablets market opportunities vary by end market size?
- How does Edoxaban Tosilate Orally Disintegrating Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Edoxaban Tosilate Orally Disintegrating Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Edoxaban Tosilate Orally Disintegrating Tablets by Country/Region, 2021, 2025 & 2032
2.2 Edoxaban Tosilate Orally Disintegrating Tablets Segment by Type
2.2.1 30 mg
2.2.2 60 mg
2.2.3 Other
2.2.4 Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type
2.2.4.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2021-2026)
2.2.4.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Price by Type (2021-2026)
2.3 Edoxaban Tosilate Orally Disintegrating Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application
2.3.4.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Breakdown Data by Company
3.1.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Company (2021-2026)
3.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Company (2021-2026)
3.2.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Price by Company
3.4 Key Manufacturers Edoxaban Tosilate Orally Disintegrating Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Edoxaban Tosilate Orally Disintegrating Tablets Product Location Distribution
3.4.2 Players Edoxaban Tosilate Orally Disintegrating Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EDOXABAN TOSILATE ORALLY DISINTEGRATING TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales Growth
4.4 APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales Growth
4.5 Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Growth
4.6 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Growth
5 AMERICAS
5.1 Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country
5.1.1 Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2021-2026)
5.1.2 Americas Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2021-2026)
5.2 Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026)
5.3 Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region
6.1.1 APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region (2021-2026)
6.1.2 APAC Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Region (2021-2026)
6.2 APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026)
6.3 APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Edoxaban Tosilate Orally Disintegrating Tablets by Country
7.1.1 Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2021-2026)
7.1.2 Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2021-2026)
7.2 Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026)
7.3 Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets by Country
8.1.1 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Edoxaban Tosilate Orally Disintegrating Tablets
10.3 Manufacturing Process Analysis of Edoxaban Tosilate Orally Disintegrating Tablets
10.4 Industry Chain Structure of Edoxaban Tosilate Orally Disintegrating Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Edoxaban Tosilate Orally Disintegrating Tablets Distributors
11.3 Edoxaban Tosilate Orally Disintegrating Tablets Customer
12 WORLD FORECAST REVIEW FOR EDOXABAN TOSILATE ORALLY DISINTEGRATING TABLETS BY GEOGRAPHIC REGION
12.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Market Size Forecast by Region
12.1.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Forecast by Region (2027-2032)
12.1.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Edoxaban Tosilate Orally Disintegrating Tablets Forecast by Type (2027-2032)
12.7 Global Edoxaban Tosilate Orally Disintegrating Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Daiichi Sankyo
13.1.1 Daiichi Sankyo Company Information
13.1.2 Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
13.1.3 Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Daiichi Sankyo Main Business Overview
13.1.5 Daiichi Sankyo Latest Developments
13.2 Menarini Group
13.2.1 Menarini Group Company Information
13.2.2 Menarini Group Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
13.2.3 Menarini Group Edoxaban Tosilate Orally Disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Menarini Group Main Business Overview
13.2.5 Menarini Group Latest Developments
13.3 Simcere Pharmaceutical
13.3.1 Simcere Pharmaceutical Company Information
13.3.2 Simcere Pharmaceutical Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
13.3.3 Simcere Pharmaceutical Edoxaban Tosilate Orally Disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Simcere Pharmaceutical Main Business Overview
13.3.5 Simcere Pharmaceutical Latest Developments
13.4 Lunan Pharmaceutical Group
13.4.1 Lunan Pharmaceutical Group Company Information
13.4.2 Lunan Pharmaceutical Group Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
13.4.3 Lunan Pharmaceutical Group Edoxaban Tosilate Orally Disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lunan Pharmaceutical Group Main Business Overview
13.4.5 Lunan Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Edoxaban Tosilate Orally Disintegrating Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Edoxaban Tosilate Orally Disintegrating Tablets by Country/Region, 2021, 2025 & 2032
2.2 Edoxaban Tosilate Orally Disintegrating Tablets Segment by Type
2.2.1 30 mg
2.2.2 60 mg
2.2.3 Other
2.2.4 Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type
2.2.4.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2021-2026)
2.2.4.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Price by Type (2021-2026)
2.3 Edoxaban Tosilate Orally Disintegrating Tablets Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application
2.3.4.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Market Share by Application (2021-2026)
2.3.4.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Breakdown Data by Company
3.1.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Company (2021-2026)
3.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Company (2021-2026)
3.2.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Price by Company
3.4 Key Manufacturers Edoxaban Tosilate Orally Disintegrating Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Edoxaban Tosilate Orally Disintegrating Tablets Product Location Distribution
3.4.2 Players Edoxaban Tosilate Orally Disintegrating Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR EDOXABAN TOSILATE ORALLY DISINTEGRATING TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Edoxaban Tosilate Orally Disintegrating Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales Growth
4.4 APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales Growth
4.5 Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Growth
4.6 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Growth
5 AMERICAS
5.1 Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country
5.1.1 Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2021-2026)
5.1.2 Americas Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2021-2026)
5.2 Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026)
5.3 Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region
6.1.1 APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region (2021-2026)
6.1.2 APAC Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Region (2021-2026)
6.2 APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026)
6.3 APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Edoxaban Tosilate Orally Disintegrating Tablets by Country
7.1.1 Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2021-2026)
7.1.2 Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2021-2026)
7.2 Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026)
7.3 Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets by Country
8.1.1 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Edoxaban Tosilate Orally Disintegrating Tablets
10.3 Manufacturing Process Analysis of Edoxaban Tosilate Orally Disintegrating Tablets
10.4 Industry Chain Structure of Edoxaban Tosilate Orally Disintegrating Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Edoxaban Tosilate Orally Disintegrating Tablets Distributors
11.3 Edoxaban Tosilate Orally Disintegrating Tablets Customer
12 WORLD FORECAST REVIEW FOR EDOXABAN TOSILATE ORALLY DISINTEGRATING TABLETS BY GEOGRAPHIC REGION
12.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Market Size Forecast by Region
12.1.1 Global Edoxaban Tosilate Orally Disintegrating Tablets Forecast by Region (2027-2032)
12.1.2 Global Edoxaban Tosilate Orally Disintegrating Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Edoxaban Tosilate Orally Disintegrating Tablets Forecast by Type (2027-2032)
12.7 Global Edoxaban Tosilate Orally Disintegrating Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Daiichi Sankyo
13.1.1 Daiichi Sankyo Company Information
13.1.2 Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
13.1.3 Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Daiichi Sankyo Main Business Overview
13.1.5 Daiichi Sankyo Latest Developments
13.2 Menarini Group
13.2.1 Menarini Group Company Information
13.2.2 Menarini Group Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
13.2.3 Menarini Group Edoxaban Tosilate Orally Disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Menarini Group Main Business Overview
13.2.5 Menarini Group Latest Developments
13.3 Simcere Pharmaceutical
13.3.1 Simcere Pharmaceutical Company Information
13.3.2 Simcere Pharmaceutical Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
13.3.3 Simcere Pharmaceutical Edoxaban Tosilate Orally Disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Simcere Pharmaceutical Main Business Overview
13.3.5 Simcere Pharmaceutical Latest Developments
13.4 Lunan Pharmaceutical Group
13.4.1 Lunan Pharmaceutical Group Company Information
13.4.2 Lunan Pharmaceutical Group Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
13.4.3 Lunan Pharmaceutical Group Edoxaban Tosilate Orally Disintegrating Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lunan Pharmaceutical Group Main Business Overview
13.4.5 Lunan Pharmaceutical Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Edoxaban Tosilate Orally Disintegrating Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Edoxaban Tosilate Orally Disintegrating Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 30 mg
Table 4. Major Players of 60 mg
Table 5. Major Players of Other
Table 6. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026) & (K Units)
Table 7. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2021-2026)
Table 8. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Type (2021-2026) & ($ million)
Table 9. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Type (2021-2026)
Table 10. Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Edoxaban Tosilate Orally Disintegrating Tablets Sale by Application (2021-2026) & (K Units)
Table 12. Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Market Share by Application (2021-2026)
Table 13. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Application (2021-2026) & ($ million)
Table 14. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Application (2021-2026)
Table 15. Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Company (2021-2026) & (K Units)
Table 17. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Company (2021-2026)
Table 18. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Company (2021-2026)
Table 20. Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Edoxaban Tosilate Orally Disintegrating Tablets Producing Area Distribution and Sales Area
Table 22. Players Edoxaban Tosilate Orally Disintegrating Tablets Products Offered
Table 23. Edoxaban Tosilate Orally Disintegrating Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share Geographic Region (2021-2026)
Table 28. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country/Region (2021-2026)
Table 32. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2021-2026) & (K Units)
Table 35. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country (2021-2026)
Table 36. Americas Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026) & (K Units)
Table 38. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026) & (K Units)
Table 39. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region (2021-2026) & (K Units)
Table 40. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Region (2021-2026)
Table 41. APAC Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026) & (K Units)
Table 43. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026) & (K Units)
Table 44. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2021-2026) & (K Units)
Table 45. Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026) & (K Units)
Table 47. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Edoxaban Tosilate Orally Disintegrating Tablets
Table 53. Key Market Challenges & Risks of Edoxaban Tosilate Orally Disintegrating Tablets
Table 54. Key Industry Trends of Edoxaban Tosilate Orally Disintegrating Tablets
Table 55. Edoxaban Tosilate Orally Disintegrating Tablets Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Edoxaban Tosilate Orally Disintegrating Tablets Distributors List
Table 58. Edoxaban Tosilate Orally Disintegrating Tablets Customer List
Table 59. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Edoxaban Tosilate Orally Disintegrating Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Edoxaban Tosilate Orally Disintegrating Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Daiichi Sankyo Basic Information, Edoxaban Tosilate Orally Disintegrating Tablets Manufacturing Base, Sales Area and Its Competitors
Table 74. Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
Table 75. Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Daiichi Sankyo Main Business
Table 77. Daiichi Sankyo Latest Developments
Table 78. Menarini Group Basic Information, Edoxaban Tosilate Orally Disintegrating Tablets Manufacturing Base, Sales Area and Its Competitors
Table 79. Menarini Group Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
Table 80. Menarini Group Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Menarini Group Main Business
Table 82. Menarini Group Latest Developments
Table 83. Simcere Pharmaceutical Basic Information, Edoxaban Tosilate Orally Disintegrating Tablets Manufacturing Base, Sales Area and Its Competitors
Table 84. Simcere Pharmaceutical Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
Table 85. Simcere Pharmaceutical Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Simcere Pharmaceutical Main Business
Table 87. Simcere Pharmaceutical Latest Developments
Table 88. Lunan Pharmaceutical Group Basic Information, Edoxaban Tosilate Orally Disintegrating Tablets Manufacturing Base, Sales Area and Its Competitors
Table 89. Lunan Pharmaceutical Group Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
Table 90. Lunan Pharmaceutical Group Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Lunan Pharmaceutical Group Main Business
Table 92. Lunan Pharmaceutical Group Latest Developments
Table 1. Edoxaban Tosilate Orally Disintegrating Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Edoxaban Tosilate Orally Disintegrating Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 30 mg
Table 4. Major Players of 60 mg
Table 5. Major Players of Other
Table 6. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026) & (K Units)
Table 7. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2021-2026)
Table 8. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Type (2021-2026) & ($ million)
Table 9. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Type (2021-2026)
Table 10. Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Edoxaban Tosilate Orally Disintegrating Tablets Sale by Application (2021-2026) & (K Units)
Table 12. Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Market Share by Application (2021-2026)
Table 13. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Application (2021-2026) & ($ million)
Table 14. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Application (2021-2026)
Table 15. Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Company (2021-2026) & (K Units)
Table 17. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Company (2021-2026)
Table 18. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Company (2021-2026)
Table 20. Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Edoxaban Tosilate Orally Disintegrating Tablets Producing Area Distribution and Sales Area
Table 22. Players Edoxaban Tosilate Orally Disintegrating Tablets Products Offered
Table 23. Edoxaban Tosilate Orally Disintegrating Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share Geographic Region (2021-2026)
Table 28. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country/Region (2021-2026)
Table 32. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2021-2026) & (K Units)
Table 35. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country (2021-2026)
Table 36. Americas Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026) & (K Units)
Table 38. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026) & (K Units)
Table 39. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Region (2021-2026) & (K Units)
Table 40. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Region (2021-2026)
Table 41. APAC Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026) & (K Units)
Table 43. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026) & (K Units)
Table 44. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2021-2026) & (K Units)
Table 45. Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026) & (K Units)
Table 47. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Edoxaban Tosilate Orally Disintegrating Tablets
Table 53. Key Market Challenges & Risks of Edoxaban Tosilate Orally Disintegrating Tablets
Table 54. Key Industry Trends of Edoxaban Tosilate Orally Disintegrating Tablets
Table 55. Edoxaban Tosilate Orally Disintegrating Tablets Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Edoxaban Tosilate Orally Disintegrating Tablets Distributors List
Table 58. Edoxaban Tosilate Orally Disintegrating Tablets Customer List
Table 59. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Edoxaban Tosilate Orally Disintegrating Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Edoxaban Tosilate Orally Disintegrating Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Daiichi Sankyo Basic Information, Edoxaban Tosilate Orally Disintegrating Tablets Manufacturing Base, Sales Area and Its Competitors
Table 74. Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
Table 75. Daiichi Sankyo Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Daiichi Sankyo Main Business
Table 77. Daiichi Sankyo Latest Developments
Table 78. Menarini Group Basic Information, Edoxaban Tosilate Orally Disintegrating Tablets Manufacturing Base, Sales Area and Its Competitors
Table 79. Menarini Group Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
Table 80. Menarini Group Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Menarini Group Main Business
Table 82. Menarini Group Latest Developments
Table 83. Simcere Pharmaceutical Basic Information, Edoxaban Tosilate Orally Disintegrating Tablets Manufacturing Base, Sales Area and Its Competitors
Table 84. Simcere Pharmaceutical Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
Table 85. Simcere Pharmaceutical Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Simcere Pharmaceutical Main Business
Table 87. Simcere Pharmaceutical Latest Developments
Table 88. Lunan Pharmaceutical Group Basic Information, Edoxaban Tosilate Orally Disintegrating Tablets Manufacturing Base, Sales Area and Its Competitors
Table 89. Lunan Pharmaceutical Group Edoxaban Tosilate Orally Disintegrating Tablets Product Portfolios and Specifications
Table 90. Lunan Pharmaceutical Group Edoxaban Tosilate Orally Disintegrating Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Lunan Pharmaceutical Group Main Business
Table 92. Lunan Pharmaceutical Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Edoxaban Tosilate Orally Disintegrating Tablets
Figure 2. Edoxaban Tosilate Orally Disintegrating Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Edoxaban Tosilate Orally Disintegrating Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country/Region (2025)
Figure 10. Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 30 mg
Figure 12. Product Picture of 60 mg
Figure 13. Product Picture of Other
Figure 14. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type in 2026
Figure 15. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Type (2021-2026)
Figure 16. Edoxaban Tosilate Orally Disintegrating Tablets Consumed in Hospital
Figure 17. Global Edoxaban Tosilate Orally Disintegrating Tablets Market: Hospital (2021-2026) & (K Units)
Figure 18. Edoxaban Tosilate Orally Disintegrating Tablets Consumed in Clinic
Figure 19. Global Edoxaban Tosilate Orally Disintegrating Tablets Market: Clinic (2021-2026) & (K Units)
Figure 20. Edoxaban Tosilate Orally Disintegrating Tablets Consumed in Other
Figure 21. Global Edoxaban Tosilate Orally Disintegrating Tablets Market: Other (2021-2026) & (K Units)
Figure 22. Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Market Share by Application (2025)
Figure 23. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Application in 2026
Figure 24. Edoxaban Tosilate Orally Disintegrating Tablets Sales by Company in 2026 (K Units)
Figure 25. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Company in 2026
Figure 26. Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Company in 2026 ($ millions)
Figure 27. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Company in 2026
Figure 28. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales 2021-2026 (K Units)
Figure 31. Americas Edoxaban Tosilate Orally Disintegrating Tablets Revenue 2021-2026 ($ millions)
Figure 32. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales 2021-2026 (K Units)
Figure 33. APAC Edoxaban Tosilate Orally Disintegrating Tablets Revenue 2021-2026 ($ millions)
Figure 34. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales 2021-2026 (K Units)
Figure 35. Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue 2021-2026 ($ millions)
Figure 38. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country in 2026
Figure 39. Americas Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Country (2021-2026)
Figure 40. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2021-2026)
Figure 41. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Application (2021-2026)
Figure 42. United States Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Region in 2026
Figure 47. APAC Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Region (2021-2026)
Figure 48. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2021-2026)
Figure 49. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Application (2021-2026)
Figure 50. China Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. India Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country in 2026
Figure 58. Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Country (2021-2026)
Figure 59. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2021-2026)
Figure 60. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Application (2021-2026)
Figure 61. Germany Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. France Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Application (2021-2026)
Figure 69. Egypt Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Edoxaban Tosilate Orally Disintegrating Tablets in 2026
Figure 75. Manufacturing Process Analysis of Edoxaban Tosilate Orally Disintegrating Tablets
Figure 76. Industry Chain Structure of Edoxaban Tosilate Orally Disintegrating Tablets
Figure 77. Channels of Distribution
Figure 78. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Forecast by Region (2027-2032)
Figure 79. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Edoxaban Tosilate Orally Disintegrating Tablets
Figure 2. Edoxaban Tosilate Orally Disintegrating Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Edoxaban Tosilate Orally Disintegrating Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country/Region (2025)
Figure 10. Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 30 mg
Figure 12. Product Picture of 60 mg
Figure 13. Product Picture of Other
Figure 14. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type in 2026
Figure 15. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Type (2021-2026)
Figure 16. Edoxaban Tosilate Orally Disintegrating Tablets Consumed in Hospital
Figure 17. Global Edoxaban Tosilate Orally Disintegrating Tablets Market: Hospital (2021-2026) & (K Units)
Figure 18. Edoxaban Tosilate Orally Disintegrating Tablets Consumed in Clinic
Figure 19. Global Edoxaban Tosilate Orally Disintegrating Tablets Market: Clinic (2021-2026) & (K Units)
Figure 20. Edoxaban Tosilate Orally Disintegrating Tablets Consumed in Other
Figure 21. Global Edoxaban Tosilate Orally Disintegrating Tablets Market: Other (2021-2026) & (K Units)
Figure 22. Global Edoxaban Tosilate Orally Disintegrating Tablets Sale Market Share by Application (2025)
Figure 23. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Application in 2026
Figure 24. Edoxaban Tosilate Orally Disintegrating Tablets Sales by Company in 2026 (K Units)
Figure 25. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Company in 2026
Figure 26. Edoxaban Tosilate Orally Disintegrating Tablets Revenue by Company in 2026 ($ millions)
Figure 27. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Company in 2026
Figure 28. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales 2021-2026 (K Units)
Figure 31. Americas Edoxaban Tosilate Orally Disintegrating Tablets Revenue 2021-2026 ($ millions)
Figure 32. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales 2021-2026 (K Units)
Figure 33. APAC Edoxaban Tosilate Orally Disintegrating Tablets Revenue 2021-2026 ($ millions)
Figure 34. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales 2021-2026 (K Units)
Figure 35. Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue 2021-2026 ($ millions)
Figure 38. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country in 2026
Figure 39. Americas Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Country (2021-2026)
Figure 40. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2021-2026)
Figure 41. Americas Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Application (2021-2026)
Figure 42. United States Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Region in 2026
Figure 47. APAC Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Region (2021-2026)
Figure 48. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2021-2026)
Figure 49. APAC Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Application (2021-2026)
Figure 50. China Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. India Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country in 2026
Figure 58. Europe Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share by Country (2021-2026)
Figure 59. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2021-2026)
Figure 60. Europe Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Application (2021-2026)
Figure 61. Germany Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. France Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share by Application (2021-2026)
Figure 69. Egypt Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Edoxaban Tosilate Orally Disintegrating Tablets Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Edoxaban Tosilate Orally Disintegrating Tablets in 2026
Figure 75. Manufacturing Process Analysis of Edoxaban Tosilate Orally Disintegrating Tablets
Figure 76. Industry Chain Structure of Edoxaban Tosilate Orally Disintegrating Tablets
Figure 77. Channels of Distribution
Figure 78. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Forecast by Region (2027-2032)
Figure 79. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Edoxaban Tosilate Orally Disintegrating Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Edoxaban Tosilate Orally Disintegrating Tablets Revenue Market Share Forecast by Application (2027-2032)
